Lipid management: considerations in acute coronary syndrome

Related Experiment Videos

Venkateshwar R Polsani1, Salim S Virani, Vijay Nambi

  • 1Department of Medicine, Baylor College of Medicine, 6565 Fannin, Houston, TX 77030, USA.

Current Atherosclerosis Reports
|February 21, 2009
PubMed

Insights

Managing dyslipidemia, especially lowering low-density lipoprotein cholesterol, is crucial for preventing coronary heart disease. Early statin therapy after acute coronary syndrome (ACS) significantly reduces cardiovascular events in high-risk patients.

Area of Science:

  • Cardiology
  • Lipidology
  • Preventive Medicine

Background:

  • Dyslipidemia management is key for coronary heart disease (CHD) prevention.
  • Low-density lipoprotein cholesterol (LDL-C) reduction is the primary therapeutic goal.
  • Acute coronary syndrome (ACS) patients face high risks of recurrent cardiovascular events.

Purpose of the Study:

  • To review the evidence on lipid alterations in patients following ACS.
  • To highlight the role of early and intensive statin therapy in ACS management.

Main Methods:

  • Literature review of studies on lipid management post-ACS.
  • Analysis of evidence supporting early statin intervention.

Main Results:

  • Intensive statin treatment initiated early after ACS is associated with decreased recurrent adverse cardiovascular events.
  • Understanding lipid alterations in ACS is critical for effective treatment.

Conclusions:

  • Early and intensive lipid-lowering therapy, particularly with statins, is vital for secondary prevention in ACS patients.
  • Targeting LDL-C remains a cornerstone in managing dyslipidemia to mitigate cardiovascular risk.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...